Literature DB >> 22305226

Hereditary angio-oedema.

Hilary Longhurst1, Marco Cicardi.   

Abstract

Hereditary angio-oedema is caused by a heterozygous deficiency of C1 inhibitor. This inhibitor regulates several inflammatory pathways, and patients with hereditary angio-oedema have intermittent cutaneous or mucosal swellings because of a failure to control local production of bradykinin. Swellings typically evolve in several hours and persist for a few days. In addition to orofacial angio-oedema, painless swellings affect peripheries, which causes disfigurement or interference with work and other activities of daily living. Angio-oedema affecting the gastrointestinal tract or abdominal viscera causes severe pain often with vomiting due to oedematous bowel obstruction. About 2% of swellings involve the larynx and can be fatal if untreated. About 50% of patients have laryngeal swellings that are potentially fatal despite prophylaxis. In this Seminar we review the clinical features, diagnosis, and management of hereditary angio-oedema, with specific emphasis on the new treatments available for acute swellings.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22305226     DOI: 10.1016/S0140-6736(11)60935-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  77 in total

Review 1.  Complement in the immunopathogenesis of rheumatic disease.

Authors:  Gunnar Sturfelt; Lennart Truedsson
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

2.  The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema.

Authors:  Francesco Arcoleo; Mariangela Lo Pizzo; Gabriella Misiano; Salvatore Milano; Giuseppina Colonna Romano; Vito Muggeo; Enrico Cillari
Journal:  Clin Exp Med       Date:  2018-04-06       Impact factor: 3.984

3.  A novel splice site mutation in the SERPING1 gene leads to haploinsufficiency by complete degradation of the mutant allele mRNA in a case of familial hereditary angioedema.

Authors:  Roger Colobran; Ricardo Pujol-Borrell; Manuel Hernández-González; Mar Guilarte
Journal:  J Clin Immunol       Date:  2014-04-24       Impact factor: 8.317

4.  Complement and contact system activation in acute congestive heart failure patients.

Authors:  C Suffritti; E Tobaldini; R Schiavon; S Strada; L Maggioni; S Mehta; G Sandrone; E Toschi-Dias; M Cicardi; N Montano
Journal:  Clin Exp Immunol       Date:  2017-08-04       Impact factor: 4.330

5.  Current state of hereditary angioedema management: a patient survey.

Authors:  Aleena Banerji; Paula Busse; Sandra C Christiansen; Henry Li; William Lumry; Mark Davis-Lorton; Jonathan A Bernstein; Michael Frank; Anthony Castaldo; Janet F Long; Bruce L Zuraw; Marc Riedl
Journal:  Allergy Asthma Proc       Date:  2015 May-Jun       Impact factor: 2.587

6.  Case 1: Recurrent abdominal pain in an adolescent girl.

Authors:  Jason A Silverman; Alfred K Yeung; Sangeeta Jain; Fotini D Kavadas
Journal:  Paediatr Child Health       Date:  2014-05       Impact factor: 2.253

Review 7.  HAE Pathophysiology and Underlying Mechanisms.

Authors:  Bruce L Zuraw; Sandra C Christiansen
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

8.  Epigenetic alterations on C1-inhibitor expression may influence hereditary angioedema attack frequency and C4 levels: Comment on: Karagianni P, Goules AV, Tzioufas AG. Epigenetic alterations in Sjogren's syndrome patient saliva.

Authors:  S Khan; H Longhurst
Journal:  Clin Exp Immunol       Date:  2020-10-05       Impact factor: 4.330

Review 9.  Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.

Authors:  Henriette Farkas
Journal:  Paediatr Drugs       Date:  2018-04       Impact factor: 3.022

10.  Drug-induced angioedema: experience of Italian emergency departments.

Authors:  G Bertazzoni; M T Spina; M G Scarpellini; F Buccelletti; M De Simone; M Gregori; V Valeriano; F R Pugliese; M P Ruggieri; M Magnanti; B Susi; L Minetola; L Zulli; F D'Ambrogio
Journal:  Intern Emerg Med       Date:  2013-11-09       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.